Literature DB >> 214025

The cerebrospinal fluid in visna, a slow viral disease of sheep.

D E Griffin, O Narayan, J F Bukowski, R J Adams, S R Cohen.   

Abstract

The temporal development of the CSF abnormalities was examined in visna, a chronic neurological disease caused by a persistent viral infection of sheep. Two types of changes were observed. During the first 30 to 40 days there was an intense mononuclear pleocytosis associated with high protein and proportionately elevated IgG. Later, there was a persistent slight pleocytosis associated with mildly elevated protein which had an increased proportion of IgG and antivisna antibody. These later cellular and protein changes are similar to those found in a number of chronic neurological diseases of man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214025     DOI: 10.1002/ana.410040304

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients.

Authors:  L Hagberg; A Forsman; G Norkrans; E Rybo; L Svennerholm
Journal:  Infection       Date:  1988       Impact factor: 3.553

2.  An ultrastructural study of the cerebrospinal fluid in visna.

Authors:  G Georgsson; J R Martin; P A Pálsson; N Nathanson; E Benediktsdóttir; G Pétursson
Journal:  Acta Neuropathol       Date:  1979-10       Impact factor: 17.088

3.  Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex.

Authors:  J Goudsmit; E C Wolters; M Bakker; L Smit; J Van der Noordaa; E A Hische; J A Tutuarima; H J Van der Helm
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-10

4.  Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice.

Authors:  D L Lodmell; L C Ewalt
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

5.  Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection.

Authors:  D Moskophidis; J Löhler; F Lehmann-Grube
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.